Covid 19 vaccine

Panacea Biotec terminates MoU with Refana for COVID-19 vaccine

Read more

Roll-out plan of Sputnik-V prompts worries about virus mutation

Read more

40 per cent participants enrolled for COVID-19 vaccine trial: Moderna

Read more

EU, CureVac may sign deal for 225 million doses of COVID-19 vaccine

Read more

Emergency authorisation for COVID-19 vaccine possible if government decides: ICMR

Read more

WHO cautions against to ‘vaccine nationalism’

Read more

Brazil regulator gives approval for human trials of J&J COVID-19 vaccine candidate

Read more

India in talks with developer of Russian COVID-19 vaccine: The Indian Express

Read more

Race to find a viable vaccine: Can Indian firms rise to the challenge?

Read more

CanSino gets COVID-19 vaccine patent from China’s IP regulator

Read more